(PharmaNewsWire.Com, May 12, 2017 ) Market Data Forecast’s research report on the Asia-Pacific Radiotherapy market estimates that the market is currently worth USD 1.15 Billion is currently growing at a CAGR of 6.82% and will reach USD 1.59 Billion by 2021
Radiotherapy uses high-energy rays to treat diseases. It can be given both externally and internally. External radiotherapy aims high-energy x-rays at the affected area using a large machine. Internal radiotherapy involves having radioactive material placed inside the body. Radiotherapy works by destroying cancer cells in the area that’s being treated. Normal cells can also be damaged by radiotherapy, which may cause side effects. Cancer cells cannot repair themselves after radiotherapy, but normal cells usually can. Radiotherapy is sometimes given with chemotherapy. This is called chemo-radiation.
The report also presents detailed analysis of multitude of factors affecting the Radiotherapy market bearing either positive or negative outcomes. Some of those factors are: • Increase in elderly population • Technological innovations in radiotherapy products • Rising conferences driving investments • Growing incidence of cancer • Mounting acceptance of radiotherapy treatments • Absence of trained personnel to perform the therapy • Practiced alternative therapy • Incapability to be used in metastatic state of cancer • Side effects associated with the treatment
The Asia-Pacific radiotherapy market is segmented on the basis of type into External beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. External beam radiation therapy is sub segmented into Image-guided radiation therapy (IGRT), Tomotherapy, Intensity-modulated radiation therapy (IMRT), Stereotactic radiosurgery, Proton therapy, and Stereotactic body radiation therapy. Based on application the market is segregated into Skin & Lip Cancer, Head & Neck Cancer, Prostate Cancer, Cervical Cancer, Breast Cancer, Lung Cancer and Spine Cancer. On the basis of equipment type market is bifurcated into Linear accelerators, Treatment planning systems and Radiation therapy simulators.
Based on geography the market is analyzed under various regions namely, China, India, Japan, South Korea and Australia. China is dominating the Asia-Pacific region radiotherapy market due to large number of elderly population in the country and is expected to continue its dominance. Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the radiotherapy market.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one-of-a kind specialties with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
